News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) and Greiner Bio-One Inc. Team to Increase HPV Test Reliability


6/25/2007 12:50:25 PM

CARLSBAD, Calif. & FRICKENHAUSEN, Germany--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Greiner Bio-One, an internationally leading technology partner for the diagnostics and pharmaceutical industry, have finalized a licensing agreement to help improve the reliability of Greiner Bio-One’s HPV-DNA-test PapilloCheck® and DNA-array CytoCheck® products. The agreement covers the rights for the use of dUTP (deoxyuridine triphosphate) in PCR-based (polymerase chain reaction) methods to prevent sample contamination by amplification products in aerosols.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES